ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 169 filers reported holding ALLAKOS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $463,000 | -59.4% | 4,037 | -50.5% | 0.03% | -68.3% |
| Q4 2020 | $1,141,000 | -53.0% | 8,151 | -72.7% | 0.08% | +3.8% |
| Q3 2020 | $2,430,000 | -17.4% | 29,830 | -27.2% | 0.08% | +3.9% |
| Q2 2020 | $2,943,000 | +179.2% | 40,952 | +72.9% | 0.08% | +171.4% |
| Q1 2020 | $1,054,000 | -55.9% | 23,690 | -5.6% | 0.03% | -17.6% |
| Q4 2019 | $2,392,000 | +236.0% | 25,083 | +177.1% | 0.03% | +325.0% |
| Q3 2019 | $712,000 | – | 9,053 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |